Lung cancer is a significant health concern due to late diagnosis. Researchers at MIT have developed nanosensors for lung cancer proteins, detectable in urine. The technology offers a noninvasive, fast, and accessible alternative to current screening methods. Challenges include potential interference factors and the need for further human testing.
toiselle kielelle
lähdeaineistosta
www.medscape.com
Tärkeimmät oivallukset
by Christina klo www.medscape.com 01-19-2024
https://www.medscape.com/viewarticle/how-simple-urine-test-could-reveal-early-stage-lung-cancer-2024a10001ibSyvällisempiä Kysymyksiä